Cargando…
Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation
Rationale: The antitumor activity of high-dose ascorbate has been re-evaluated recently, but the mechanism underlying cell-specific sensitivity to ascorbate has not yet been clarified. Methods: The effects of high-dose ascorbate on gastric cancer were assessed using cancer cell lines with high and l...
Autores principales: | Lu, Yun-Xin, Wu, Qi-Nian, Chen, Dong-liang, Chen, Le-Zong, Wang, Zi-Xian, Ren, Chao, Mo, Hai-yu, Chen, Ya, Sheng, Hui, Wang, Ying-Nan, Wang, Yun, Lu, Jia-Huan, Wang, De-shen, Zeng, Zhao-lei, Wang, Feng, Wang, Feng-Hua, Li, Yu-Hong, Ju, Huai-Qiang, Xu, Rui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835938/ https://www.ncbi.nlm.nih.gov/pubmed/29507622 http://dx.doi.org/10.7150/thno.21745 |
Ejemplares similares
-
Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer
por: Chen, Zhan-Hong, et al.
Publicado: (2019) -
Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications
por: Ju, Huai-Qiang, et al.
Publicado: (2018) -
GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer
por: Yang, Jing, et al.
Publicado: (2016) -
Antitumoral effects of pharmacological ascorbate on gastric cancer cells: GLUT1 expression may not tell the whole story
por: Corti, Alessandro, et al.
Publicado: (2018) -
Hepatomas are exquisitely sensitive to pharmacologic ascorbate (P-AscH(-))
por: Zhang, Xuan, et al.
Publicado: (2019)